Supreme Court Rebuffs Pharmaceutical Manufacturers’ Bid to Upend Medicare Drug Price Negotiations
- May 22, 2026
- Written by AHLA Legal Staff
The Supreme Court declined May 18, without comment, to review several decisions rejecting six major pharmaceutical manufacturers’ challenges to the Medicare drug price negotiation program.
ARTICLE TAGS
You must be logged in to access this content.